Drug Safety update: Methylprednisolone injectable medicine containing lactose (Solu-Medrone 40 mg)

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update for Solu-Medrone 40 mg. Solu-Medrone 40 mg may contain trace amounts of milk proteins. Do not use in patients with a known or suspected allergy to cows’ milk.

Further details of the safety update, advice and recommendations are available on the MHRA website.